Related content

The use of MCP-1 and soluble CD40 ligand in a pathophysiology-guided approach to the management of coronary artery disease

By Mo Vivian Y   de Lemos James A  

Future Cardiology, Vol. 1, Iss. 5, 2005-09 ,pp. : 649-656

Future Medicine

Access to resources Recommend Favorite

Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation

By Yngen M.   Östenson C.-G.   Hu H.   Li N.   Hjemdahl P.   Wallén N.  

Diabetologia, Vol. 47, Iss. 3, 2004-03 ,pp. : 537-540

Springer Publishing Company

Access to resources Recommend Favorite

Circulating soluble CD40 ligand mediates the interaction between neutrophils and platelets in acute coronary syndrome

By Setianto Budi   Hartopo Anggoro   Gharini Putrika   Anggrahini Dyah   Irawan Bambang  

Heart and Vessels, Vol. 25, Iss. 4, 2010-07 ,pp. : 282-287

Springer Publishing Company

Access to resources Recommend Favorite

Soluble CD23 and Interleukin-1 Receptor Antagonist in Human Asthmatics Following Antigen Challenge

By Amrol David   Hagaman David   Sheller James   Murray John  

Journal of Asthma, Vol. 42, Iss. 1, 2005-02 ,pp. : 73-76

Informa Healthcare

Access to resources Recommend Favorite

Increased Th17 cells in coronary artery disease are associated with neutrophilic inflammation

By Wang Zikuan   Lee Jun   Zhang Ye   Wang Hongtao   Liu Xiongtao   Shang Fujun   Zheng Qiangsun  

Scandinavian Cardiovascular Journal, Vol. 45, Iss. 1, 2011-02 ,pp. : 54-61

Informa Healthcare

Access to resources Recommend Favorite